What ChondroFiller injection typically costs in the UK

ChondroFiller injection guide costs in the UK run from approximately £2,100 for smaller joint treatments up to £8,000 for multi-compartment or revision cases. For most patients — those with a single focal cartilage defect — the relevant figure is around £3,000, which covers a one-box course of treatment.

Pricing follows a straightforward volume-based tier:

• One box (~£3,000): a single focal defect in one compartment — the most common clinical scenario
• Two boxes (~£5,500): a larger defect or involvement of two compartments
• Three boxes (~£8,000): multi-compartment damage or a revision case

The number of boxes required is determined at assessment, based on defect size and how many joint compartments are affected. Because the majority of patients present with a single focal defect, most fall into the one-box tier.

These figures reflect guide costs published by London Cartilage Clinic on Harley Street, which was the first UK clinic to offer ChondroFiller as an injection. Pricing is not standardised across providers, and some clinics quote from as low as £2,100 for smaller joints. Before booking, patients should request written confirmation of what is included in the quoted fee — a well-structured price should cover consultation, the ChondroFiller implant itself, ultrasound guidance, and a follow-up appointment.

Why ChondroFiller costs more than standard joint injections

The gap between ChondroFiller and a standard joint injection is not a margin decision — it reflects what the product actually is.

ChondroFiller is a CE-marked Class III medical device, the highest regulatory tier in the EU/UK framework for implantable products. That classification is reserved for devices that interact actively with the body's biology — in this case, an acellular collagen scaffold that gels within the defect and recruits the patient's own progenitor cells through a process called matrix-induced chondrogenesis. Achieving and maintaining Class III status requires Meidrix Biomedicals GmbH, the German manufacturer, to meet strict quality, safety, and manufacturing standards across every production batch. The product is imported under prescription, adding a further regulated supply chain to the cost structure.

The practical consequence is that the implant itself — not the clinical time — is the largest component of the overall fee. With a standard corticosteroid or hyaluronic acid injection, the clinical appointment typically accounts for the majority of the cost; the injectate is relatively inexpensive. Neither corticosteroid nor hyaluronic acid carries Class III status — both are symptom-management injectables, not regenerative scaffolds — and their pricing reflects that difference in regulatory and manufacturing complexity.

What an all-inclusive fee should cover

A well-structured ChondroFiller quote — as published by London Cartilage Clinic — is all-inclusive and should contain five components:

• Initial consultation to assess defect size and confirm suitability
• Real-time ultrasound guidance for image-guided placement of the scaffold
• The ChondroFiller implant itself — typically the largest single cost item
• IV antibiotic cover administered during the procedure
• A six-week follow-up appointment to review progress

If any of these are listed separately, the headline figure will understate the true cost.

Some patients are offered combination packages that pair ChondroFiller with a second injectable. The most common is ChondroFiller with Arthrosamid (a polyacrylamide hydrogel), priced at approximately £6,000 and intended for patients with KL Grade III or IV osteoarthritis alongside a focal defect. A Tri-Active package — ChondroFiller, Arthrosamid, and MSC cells — is available at approximately £11,000. It is worth understanding that these are two distinct mechanisms working in parallel: ChondroFiller is the regenerative scaffold component, promoting matrix-induced chondrogenesis; Arthrosamid is a non-regenerative hydrogel providing joint-space support. They are not interchangeable, and combining them addresses different aspects of the joint.

What to expect at the outpatient appointment

For most patients, the question behind the pricing is really a simpler one: will this involve surgery? The answer is no.

The ChondroFiller injection is an outpatient appointment of approximately 30–45 minutes, carried out under local anaesthesia or mild sedation. There is no operating theatre, no surgical incision, and no general anaesthetic. Patients leave the clinic the same day.

Placement is performed under real-time ultrasound or fluoroscopic guidance — image-guided delivery into the fluid joint environment. That approach is what mechanically distinguishes ChondroFiller from surgical cartilage repair techniques, which require a dry operative field and theatre conditions. Here, the guidance serves a precise clinical purpose: positioning the injectable scaffold accurately within the defect so it can gel in situ and begin its work. No hospital admission is involved before or after.

ChondroFiller can be delivered across multiple joints — knee, hip, and ankle most commonly, with shoulder, elbow, wrist, and smaller hand joints also treated — and the same outpatient format applies regardless of which joint is involved.

NHS availability and private insurance

ChondroFiller injection is available exclusively through private self-funded practice in the UK. There is no NHS commissioning pathway for it, and no referral route that will bring the cost under NHS funding.

The only cartilage cell therapy currently funded by the NHS for knee defects is autologous chondrocyte implantation (ACI), approved in 2017. ACI is a two-stage surgical procedure — it sits on a separate operative pathway and is not an injection equivalent. Patients who are ineligible for or uninterested in surgery, or who do not meet ACI criteria, will not find an NHS-funded injection alternative.

Private medical insurance

Some private medical insurance (PMI) policies do cover ChondroFiller. The procedures are billed under CCSD codes W3111 (cartilage regeneration with collagen scaffold) and W8500; quoting these codes to your insurer at the outset will help clarify whether the treatment falls within your policy. Approvals have most commonly been reported with Bupa, Aviva, and WPA, though coverage is not guaranteed and varies considerably by policy type and individual terms.

Written pre-authorisation from the insurer must be obtained before treatment begins — not after. London Cartilage Clinic on Harley Street, the first UK clinic to offer ChondroFiller as an injection, can provide the clinical documentation needed to support an authorisation request. Guide costs, confirmed by the treating clinic, should be supplied to the insurer at the same time so that any shortfall between the policy limit and the actual fee is understood in advance.

If your insurer declines or your policy does not include this treatment, the guide costs outlined earlier in this article represent what patients typically pay on a self-funded basis.

How ChondroFiller sits in the broader UK cartilage treatment landscape

The pricing context becomes clearer when ChondroFiller injection is placed alongside the surgical alternatives it most often sits beside. Microfracture — the most accessible surgical option — runs to around £4,000 privately. OATS (osteochondral autograft transfer) is typically around £14,000. Single-stage cartilage implantation or osteochondral allograft replacement can reach £28,000. Each of those involves an operating theatre, general or spinal anaesthesia, and a rehabilitation period measured in months rather than weeks.

ChondroFiller injection, at £3,000–£8,000 depending on defect volume, sits below all of them — and is delivered as an outpatient appointment with no hospital admission and no surgical incision.

That comparison has limits worth being clear about. ChondroFiller is not a universal substitute for surgical repair: defect size, joint condition, and overall cartilage health all affect whether the injectable scaffold pathway is appropriate. Some patients will still be better served by surgery. A clinical assessment is what determines which route fits.

For patients who want to explore whether they qualify, the London Cartilage Clinic on Harley Street — the UK's certified delivery centre for ChondroFiller injection — offers assessments and can be reached at londoncartilage.com.